FULL TEST BANK FORFORD: INTRODUCTORY CLINICAL PHARMACOLOGY 12TH
EDITION BY SUSAN FORD CHAPTERS 1-54 QUESTIONS AND ANSWERS A+
,Contents
Chapter 01: General Principles of Pharmacology .............................................................................4
Chapter 02, Administration of Drugs ............................................................................................. 25
Chapter 03, Making Drug Dosing Safer .......................................................................................... 45
Chapter 04, The Nursing Process ................................................................................................... 62
Chapter 05, Patient and Family Teaching....................................................................................... 80
Chapter 06, Antibacterial Drugs: Sulfonamides............................................................................ 101
Chapter 07, Antibacterial Drugs That Disrupt the Bacterial Cell Wall ............................................ 120
Chapter 08, Antibacterial Drugs That Interfere With Protein Synthesis......................................... 141
Chapter 09, Antibacterial Drugs That Interfere With DNA/RNA Synthesis..................................... 157
Chapter 10, Antitubercular Drugs................................................................................................ 175
Chapter 11, Antiviral Drugs ......................................................................................................... 193
Chapter 12, Antifungal and Antiparasitic Drugs ........................................................................... 211
Chapter 13, Nonopioid Analgesics: Salicylates and Nonsalic- ylates.............................................. 230
Chapter 14, Nonopioid Analgesics: Nonsteroidal An- ................................................................... 246
ti-Inflammatory Drugs (NSAIDs) and Migraine Headache Medications ......................................... 246
Chapter 15, Opioid Analgesics..................................................................................................... 264
Chapter 16, Anesthetic Drugs...................................................................................................... 279
Chapter 17, Central Nervous System Stimulants .......................................................................... 295
Chapter 18, Antidementia Drugs ................................................................................................. 311
Chapter 19, Antianxiety Drugs .................................................................................................... 329
Chapter 20, Sedatives and Hypnotics .......................................................................................... 346
Chapter 21, Antidepressant Drugs............................................................................................... 362
Chapter 22, Antipsychotic Drugs ................................................................................................. 381
Chapter 23, Adrenergic Drugs ..................................................................................................... 397
Chapter 24, Adrenergic Blocking Drugs........................................................................................ 414
Chapter 25, Cholinergic Drugs ..................................................................................................... 429
Chapter: 26, Cholinergic Blocking Drugs ...................................................................................... 446
Chapter 27, Antiparkinson Drugs ................................................................................................ 464
Chapter 28, Antiepileptics .......................................................................................................... 482
Chapter 29, Skeletal Muscle, Bone, and Joint Disorder Drugs ....................................................... 500
Chapter 30, Upper Respiratory System Drugs .............................................................................. 517
Chapter 31, Lower Respiratory System Drugs .............................................................................. 535
,Chapter 32, Diuretics .................................................................................................................. 552
Chapter 33, Antihyperlipidemic Drugs ......................................................................................... 568
Chapter 34, Antihypertensive Drugs............................................................................................ 585
Chapter 35, Antianginal and Vasodilating Drugs .......................................................................... 602
Chapter 36, Anticoagulant and Thrombolytic Drugs ..................................................................... 619
Chapter 37, Cardiotonic and Antiarrhythmic Drugs ...................................................................... 636
Chapter 38, Upper Gastrointestinal System Drugs ....................................................................... 651
Chapter 39, Lower Gastrointestinal System Drugs ....................................................................... 667
Chapter 40, Antidiabetic Drugs ................................................................................................... 685
Chapter 41, Pituitary and Adrenocortical Hormones .................................................................... 711
Chapter 42, Thyroid and Antithyroid Drugs ................................................................................. 739
Chapter 43, Male and Female Hormones..................................................................................... 762
Chapter 44, Uterine Drugs .......................................................................................................... 788
Chapter 45, Menopause and Andropause Drugs .......................................................................... 817
Chapter: 46, Urinary Tract Anti-Infectives and Other Urinary Drugs ............................................. 842
Chapter 47, Vaccines .................................................................................................................. 866
Chapter 48, Immunostimulants and Immunomodulators ............................................................. 893
Chapter 49: Immune Blockers ..................................................................................................... 918
Chapter 50, Traditional Chemotherapy ....................................................................................... 941
Chapter 51: Immune Modulating Therapies ................................................................................ 966
Chapter 52, Skin Disorder Topical Drugs ...................................................................................... 988
Chapter 53, Otic and Ophthalmic Preparations .......................................................................... 1015
Chapter 54, Fluids, Electrolytes, and Parenteral Therapy ........................................................... 1040
,Chapter 01: General Principles of Pharmacology
1. After teaching a group of students about the basics of pharmacology, the students will be able
to choose which aspect as the most critical to remember?
A) Drug name
B) Drug class
C) Drug action
D) Drug source
Answer: C
Rationale: Pharmacology is the study of drugs and its action on living organisms. Thus, an essential
aspect of pharmacology is drug action. An understanding of the drug name, drug class, and drug source
is important, but the most critical aspect related to pharmacology is how the drug acts in the body.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 1 Cognitive Level: Apply
Client Needs: Physiological Integrity: Pharmacological Therapies Integrated Process: Teaching/Learning
Reference: p. 3, Introduction
2. A nurse suspects the client had an adverse reaction to a prescribed medication due to an
interaction with an unreported over-the-counter supplement. Which action by the nurse will best assist
in preventing future similar incidents?
A) File a report with MedWatch
B) File a report with the State Board of Nursing
C) Instruct the client to avoid combining medications in the future
D) Document the incident and report it to the health care provider
Answer: A
,Rationale: Nurses play an important role in monitoring for adverse reactions. Therefore, it is important
to submit reports, even if there is uncertainty about the cause–effect relationship. The FDA protects the
identity of those who voluntarily report adverse reactions.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 9 Cognitive Level: Apply
Client Needs: Safe and Effective Care Environment: Safety and InfectionControl
Integrated Process: Clinical Problem-solving Process (Nursing Process) Reference: p. 7, Box 1.1
MedWatch and Reporting Adverse Events
3. A nurse is assessing a client and notes the client has developed swelling of the eyelids and lips
after administration of a prescribed medication. What does the nurse interpret this finding to
specifically indicate?
A) Mild allergic reaction
B) Anaphylactic shock
C) Angioedema
D) Drug idiosyncrasy
Answer: C
Rationale: Angioedema is a type of allergic drug reaction manifested by the collection of fluid in the
subcutaneous tissues, most commonly affecting the eyelids, lips, mouth, and throat. Allergic reactions
can be manifested by a wide range of signs and symptoms such as itching, rashes, and hives.
Anaphylactic shock is a serious allergic reaction that requires immediate medical attention. Drug
idiosyncrasy describes anyunusual or abnormal reaction to a drug, one that is different from the one
normally expected.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 5 Cognitive Level: Apply
Client Needs: Physiological Integrity: Reduction of Risk Potential Integrated Process: Clinical Problem-
solving Process (Nursing Process) Reference: p. 12, Allergic Drug Reactions
4. The nurse is preparing to teach a client about a new drug which is in the fourth phase of
development. Which activity will the nurse explain best illustrates this phase?
,A) Health care providers report adverse effects to FDA.
B) Healthy volunteers are involved in the test.
C) In vitro tests are performed using human cells.
D) The drug is given to clients with the disease.
Answer: A
Rationale: The postmarketing surveillance phase of drug development encourages health care
professionals to report adverse effects of drugs to the FDA using MedWatch. Phase 1 of clinical testing
involves 20 to 100 healthy volunteers. In vitro testing of the drug on human or animal cells is done in the
pre-FDA phase. In Phase 2 of clinical testing, the drug is given to clients with the disease for which the
drug is manufactured.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 4 Cognitive Level: Apply
Client Needs: Health Promotion and Maintenance Integrated Process: Teaching/Learning Reference: p.
7, Concept Mastery Alert
5. A nurse is assessing a pregnant client who admits to having a cocaine addiction. Which condition
of the baby after birth should the nurse explain and preparethe client for?
A) Diabetes
B) Hypertension
C) Addiction to drugs
D) CNS defects
Answer: C
, Rationale: The nurse informs the client that children born to mothers using addictive drugs are often
born with an addiction to the drug. Children born to mothers who are addicted to cocaine are not
known to be born with diabetes, CNS defects, or hypertension.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 6 Cognitive Level: Apply
Client Needs: Health Promotion and Maintenance Integrated Process: Teaching/Learning
Reference: p. 11, Drug Use, Pregnancy, and Lactation
6. A client arrives at the health care clinic and reports taking several pills for a headache and
severe cough without relief. Which adverse effect should the nurse be aware may develop from this
combination?
A) Gastrointestinal bleeding
B) Breathing difficulties
C) Liver damage
D) Anaphylaxis
Answer: C
Rationale: Consumers should be urged to carefully read the directions before taking over- the-counter
(OTC) drugs, as these drugs are not without risks. For example, acetaminophen, commonly used for pain
relief, is also found in many OTC products, such as cough and cold remedies. When taken for both pain
and in a cold remedy, this accumulative amount of the drug can potentially harm a person's liver. Aspirin
presents the potential adverse reaction of gastrointestinal bleeding. An allergic reaction could result in
breathing difficulties and anaphylaxis.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 5 Cognitive Level: Apply
Client Needs: Physiological Integrity: Pharmacological Therapies Integrated Process: Clinical Problem-
solving Process (Nursing Process) Reference: p. 5, Nonprescription Drugs
7. The nurse notes on assessment after administration of a drug that the clienthas developed
itching and a skin rash. The nurse interprets these findings as indicating which possible reaction?
A) Toxicity
B) Allergic reaction
C) Angioedema
D) Crystalluria
EDITION BY SUSAN FORD CHAPTERS 1-54 QUESTIONS AND ANSWERS A+
,Contents
Chapter 01: General Principles of Pharmacology .............................................................................4
Chapter 02, Administration of Drugs ............................................................................................. 25
Chapter 03, Making Drug Dosing Safer .......................................................................................... 45
Chapter 04, The Nursing Process ................................................................................................... 62
Chapter 05, Patient and Family Teaching....................................................................................... 80
Chapter 06, Antibacterial Drugs: Sulfonamides............................................................................ 101
Chapter 07, Antibacterial Drugs That Disrupt the Bacterial Cell Wall ............................................ 120
Chapter 08, Antibacterial Drugs That Interfere With Protein Synthesis......................................... 141
Chapter 09, Antibacterial Drugs That Interfere With DNA/RNA Synthesis..................................... 157
Chapter 10, Antitubercular Drugs................................................................................................ 175
Chapter 11, Antiviral Drugs ......................................................................................................... 193
Chapter 12, Antifungal and Antiparasitic Drugs ........................................................................... 211
Chapter 13, Nonopioid Analgesics: Salicylates and Nonsalic- ylates.............................................. 230
Chapter 14, Nonopioid Analgesics: Nonsteroidal An- ................................................................... 246
ti-Inflammatory Drugs (NSAIDs) and Migraine Headache Medications ......................................... 246
Chapter 15, Opioid Analgesics..................................................................................................... 264
Chapter 16, Anesthetic Drugs...................................................................................................... 279
Chapter 17, Central Nervous System Stimulants .......................................................................... 295
Chapter 18, Antidementia Drugs ................................................................................................. 311
Chapter 19, Antianxiety Drugs .................................................................................................... 329
Chapter 20, Sedatives and Hypnotics .......................................................................................... 346
Chapter 21, Antidepressant Drugs............................................................................................... 362
Chapter 22, Antipsychotic Drugs ................................................................................................. 381
Chapter 23, Adrenergic Drugs ..................................................................................................... 397
Chapter 24, Adrenergic Blocking Drugs........................................................................................ 414
Chapter 25, Cholinergic Drugs ..................................................................................................... 429
Chapter: 26, Cholinergic Blocking Drugs ...................................................................................... 446
Chapter 27, Antiparkinson Drugs ................................................................................................ 464
Chapter 28, Antiepileptics .......................................................................................................... 482
Chapter 29, Skeletal Muscle, Bone, and Joint Disorder Drugs ....................................................... 500
Chapter 30, Upper Respiratory System Drugs .............................................................................. 517
Chapter 31, Lower Respiratory System Drugs .............................................................................. 535
,Chapter 32, Diuretics .................................................................................................................. 552
Chapter 33, Antihyperlipidemic Drugs ......................................................................................... 568
Chapter 34, Antihypertensive Drugs............................................................................................ 585
Chapter 35, Antianginal and Vasodilating Drugs .......................................................................... 602
Chapter 36, Anticoagulant and Thrombolytic Drugs ..................................................................... 619
Chapter 37, Cardiotonic and Antiarrhythmic Drugs ...................................................................... 636
Chapter 38, Upper Gastrointestinal System Drugs ....................................................................... 651
Chapter 39, Lower Gastrointestinal System Drugs ....................................................................... 667
Chapter 40, Antidiabetic Drugs ................................................................................................... 685
Chapter 41, Pituitary and Adrenocortical Hormones .................................................................... 711
Chapter 42, Thyroid and Antithyroid Drugs ................................................................................. 739
Chapter 43, Male and Female Hormones..................................................................................... 762
Chapter 44, Uterine Drugs .......................................................................................................... 788
Chapter 45, Menopause and Andropause Drugs .......................................................................... 817
Chapter: 46, Urinary Tract Anti-Infectives and Other Urinary Drugs ............................................. 842
Chapter 47, Vaccines .................................................................................................................. 866
Chapter 48, Immunostimulants and Immunomodulators ............................................................. 893
Chapter 49: Immune Blockers ..................................................................................................... 918
Chapter 50, Traditional Chemotherapy ....................................................................................... 941
Chapter 51: Immune Modulating Therapies ................................................................................ 966
Chapter 52, Skin Disorder Topical Drugs ...................................................................................... 988
Chapter 53, Otic and Ophthalmic Preparations .......................................................................... 1015
Chapter 54, Fluids, Electrolytes, and Parenteral Therapy ........................................................... 1040
,Chapter 01: General Principles of Pharmacology
1. After teaching a group of students about the basics of pharmacology, the students will be able
to choose which aspect as the most critical to remember?
A) Drug name
B) Drug class
C) Drug action
D) Drug source
Answer: C
Rationale: Pharmacology is the study of drugs and its action on living organisms. Thus, an essential
aspect of pharmacology is drug action. An understanding of the drug name, drug class, and drug source
is important, but the most critical aspect related to pharmacology is how the drug acts in the body.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 1 Cognitive Level: Apply
Client Needs: Physiological Integrity: Pharmacological Therapies Integrated Process: Teaching/Learning
Reference: p. 3, Introduction
2. A nurse suspects the client had an adverse reaction to a prescribed medication due to an
interaction with an unreported over-the-counter supplement. Which action by the nurse will best assist
in preventing future similar incidents?
A) File a report with MedWatch
B) File a report with the State Board of Nursing
C) Instruct the client to avoid combining medications in the future
D) Document the incident and report it to the health care provider
Answer: A
,Rationale: Nurses play an important role in monitoring for adverse reactions. Therefore, it is important
to submit reports, even if there is uncertainty about the cause–effect relationship. The FDA protects the
identity of those who voluntarily report adverse reactions.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 9 Cognitive Level: Apply
Client Needs: Safe and Effective Care Environment: Safety and InfectionControl
Integrated Process: Clinical Problem-solving Process (Nursing Process) Reference: p. 7, Box 1.1
MedWatch and Reporting Adverse Events
3. A nurse is assessing a client and notes the client has developed swelling of the eyelids and lips
after administration of a prescribed medication. What does the nurse interpret this finding to
specifically indicate?
A) Mild allergic reaction
B) Anaphylactic shock
C) Angioedema
D) Drug idiosyncrasy
Answer: C
Rationale: Angioedema is a type of allergic drug reaction manifested by the collection of fluid in the
subcutaneous tissues, most commonly affecting the eyelids, lips, mouth, and throat. Allergic reactions
can be manifested by a wide range of signs and symptoms such as itching, rashes, and hives.
Anaphylactic shock is a serious allergic reaction that requires immediate medical attention. Drug
idiosyncrasy describes anyunusual or abnormal reaction to a drug, one that is different from the one
normally expected.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 5 Cognitive Level: Apply
Client Needs: Physiological Integrity: Reduction of Risk Potential Integrated Process: Clinical Problem-
solving Process (Nursing Process) Reference: p. 12, Allergic Drug Reactions
4. The nurse is preparing to teach a client about a new drug which is in the fourth phase of
development. Which activity will the nurse explain best illustrates this phase?
,A) Health care providers report adverse effects to FDA.
B) Healthy volunteers are involved in the test.
C) In vitro tests are performed using human cells.
D) The drug is given to clients with the disease.
Answer: A
Rationale: The postmarketing surveillance phase of drug development encourages health care
professionals to report adverse effects of drugs to the FDA using MedWatch. Phase 1 of clinical testing
involves 20 to 100 healthy volunteers. In vitro testing of the drug on human or animal cells is done in the
pre-FDA phase. In Phase 2 of clinical testing, the drug is given to clients with the disease for which the
drug is manufactured.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 4 Cognitive Level: Apply
Client Needs: Health Promotion and Maintenance Integrated Process: Teaching/Learning Reference: p.
7, Concept Mastery Alert
5. A nurse is assessing a pregnant client who admits to having a cocaine addiction. Which condition
of the baby after birth should the nurse explain and preparethe client for?
A) Diabetes
B) Hypertension
C) Addiction to drugs
D) CNS defects
Answer: C
, Rationale: The nurse informs the client that children born to mothers using addictive drugs are often
born with an addiction to the drug. Children born to mothers who are addicted to cocaine are not
known to be born with diabetes, CNS defects, or hypertension.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 6 Cognitive Level: Apply
Client Needs: Health Promotion and Maintenance Integrated Process: Teaching/Learning
Reference: p. 11, Drug Use, Pregnancy, and Lactation
6. A client arrives at the health care clinic and reports taking several pills for a headache and
severe cough without relief. Which adverse effect should the nurse be aware may develop from this
combination?
A) Gastrointestinal bleeding
B) Breathing difficulties
C) Liver damage
D) Anaphylaxis
Answer: C
Rationale: Consumers should be urged to carefully read the directions before taking over- the-counter
(OTC) drugs, as these drugs are not without risks. For example, acetaminophen, commonly used for pain
relief, is also found in many OTC products, such as cough and cold remedies. When taken for both pain
and in a cold remedy, this accumulative amount of the drug can potentially harm a person's liver. Aspirin
presents the potential adverse reaction of gastrointestinal bleeding. An allergic reaction could result in
breathing difficulties and anaphylaxis.
Question Format: Multiple Choice Chapter: 1
Learning Objective: 5 Cognitive Level: Apply
Client Needs: Physiological Integrity: Pharmacological Therapies Integrated Process: Clinical Problem-
solving Process (Nursing Process) Reference: p. 5, Nonprescription Drugs
7. The nurse notes on assessment after administration of a drug that the clienthas developed
itching and a skin rash. The nurse interprets these findings as indicating which possible reaction?
A) Toxicity
B) Allergic reaction
C) Angioedema
D) Crystalluria
